47109-4 |
Gentamicin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Gentamicin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47109-4 |
|
|
|
|
Both |
|
|
|
0 |
Gentamicin SerPl-sCnc |
|
|
|
N |
|
Aminoglycosides; c213; DRUG/TOXICOLOGY; Drugs; Garamycin; Genirr; Genj; Gent; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
4711-8 |
HLA-A74(19) |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-A74(19) [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4711-8 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A74(19) Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47110-2 |
Glutethimide |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Glutethimide [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47110-2 |
|
|
|
|
Both |
|
|
|
0 |
Glutethimide Gast-sCnc |
|
|
|
N |
|
Addiction; Doriden; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Glutethimde; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47111-0 |
Glutethimide |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Glutethimide [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47111-0 |
|
|
|
|
Both |
|
|
|
0 |
Glutethimide Ur-sCnc |
|
|
|
N |
|
Addiction; Doriden; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Glutethimde; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47112-8 |
Gold |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Gold [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
47112-8 |
|
|
|
|
Both |
|
|
|
0 |
Gold 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; AU; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
47113-6 |
Gold/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Gold/Creatinine [Molar ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/mmol creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
47113-6 |
|
|
|
|
Both |
|
|
|
0 |
Gold/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; AU; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/mmol{creat} |
|
|
|
0 |
47114-4 |
LORazepam |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
LORazepam [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47114-4 |
|
|
|
|
Both |
|
|
|
0 |
LORazepam Gast-sCnc |
|
|
|
N |
|
Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47115-1 |
LORazepam |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
LORazepam [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47115-1 |
|
|
|
|
Both |
|
|
|
0 |
LORazepam Ur-sCnc |
|
|
|
N |
|
Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.73 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47116-9 |
Manganese |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Manganese [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47116-9 |
|
|
|
|
Both |
|
|
|
0 |
Manganese Gast-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; MN; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47117-7 |
Maprotiline |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Maprotiline [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47117-7 |
|
|
|
|
Both |
|
|
|
0 |
Maprotiline Gast-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Ludiomil; Novartis; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47118-5 |
Maprotiline |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Maprotiline [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47118-5 |
|
|
|
|
Both |
|
|
|
0 |
Maprotiline Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Ludiomil; Novartis; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
47119-3 |
Meprobamate |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Meprobamate [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47119-3 |
|
|
|
|
Both |
|
|
|
0 |
Meprobamate Gast-sCnc |
|
|
|
N |
|
Addiction; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GAST; Gastric contents; Gastric fluid; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
4712-6 |
HLA-A74(19) |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-A74(19) [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4712-6 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A74(19) Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47120-1 |
Meprobamate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Meprobamate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47120-1 |
|
|
|
|
Both |
|
|
|
0 |
Meprobamate Ur-sCnc |
|
|
|
N |
|
Addiction; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; Illicit; Level; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47121-9 |
Mercury |
SCnt |
XXX |
Pt |
Qn |
|
|
ACTIVE |
Mercury [Moles/mass] in Specimen |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
47121-9 |
|
|
|
|
Both |
|
|
|
0 |
Mercury Spec-sCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; HG; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Substance Content; To be specified in another part of the message; Unspecified |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
47122-7 |
Methyprylon |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Methyprylon [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47122-7 |
|
|
|
|
Both |
|
|
|
0 |
Methyprylon Gast-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Methprylon; Noludar; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47123-5 |
Nickel |
SCnt |
Hair |
Pt |
Qn |
|
|
ACTIVE |
Nickel [Moles/mass] in Hair |
|
MIN |
DefinitionDescription |
|
|
nmol/g |
|
|
|
|
|
|
DRUG/TOX |
|
47123-5 |
|
|
|
|
Both |
|
|
|
0 |
Nickel Hair-sCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Har; NI; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance content |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/g |
|
|
|
0 |
47124-3 |
PHENobarbital |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
PHENobarbital [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47124-3 |
|
|
|
|
Both |
|
|
|
0 |
Phenobarb Gast-sCnc |
|
|
|
N |
|
Barbiturate; c417; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Luminal; Nirvonal; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47125-0 |
Primidone |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Primidone [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47125-0 |
|
|
|
|
Both |
|
|
|
0 |
Primidone Gast-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Mysoline; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47126-8 |
Protriptyline |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Protriptyline [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47126-8 |
|
|
|
|
Both |
|
|
|
0 |
Protrip Gast-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Vivactil |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47127-6 |
Protriptyline |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Protriptyline [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47127-6 |
|
|
|
|
Both |
|
|
|
0 |
Protrip Ur-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn; Vivactil |
2.7 |
2.19 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
47128-4 |
Salicylates |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Salicylates [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47128-4 |
|
|
|
|
Both |
|
|
|
0 |
Salicylates Gast-sCnc |
|
|
|
N |
|
2-Hydroxybenzoate; 2-Hydroxybenzoic Acid; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Level; o-Hydroxybenzoate; o-Hydroxybenzoic Acid; ortho-Hydroxybenzoate; ortho-Hydroxybenzoic Acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sali; Salicilates; Salicylate; Salicylic acid; Substance concentration |
2.7 |
2.19 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
47129-2 |
Silver |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Silver [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
47129-2 |
|
|
|
|
Both |
|
|
|
0 |
Silver 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Ag; DRUG/TOXICOLOGY; Drugs; QNT; Quan; Quant; Quantitative; Silv; sRate; Substance Rate; UA; UR; Urn |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
4713-4 |
HLA-A10 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-A10 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4713-4 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-A10 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
47130-0 |
Thallium |
SCnc |
RBC |
Pt |
Qn |
|
|
ACTIVE |
Thallium [Moles/volume] in Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
47130-0 |
|
|
|
|
Both |
|
|
|
0 |
Thallium RBC-sCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Erythrocytes; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance concentration; TL |
2.7 |
2.19 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |